Estimation of fatty liver disease clinical role on glucose metabolic remodelling phenotypes and T2DM onset.
Diego Martinez-UrbistondoAna HuertaDavid Navarro-GonzálezLaura Sánchez-IñigoAlejandro Fernandez-MonteroManuel F LandechoJosé Alfredo Martínez HernándezJuan C Pastrana-DelgadoPublished in: European journal of clinical investigation (2023)
MAFLD interplay with MetS and PreDM might help to discriminate patient risk of T2DM in the clinical setting through metabolic remodelling-based phenotypes.